Attached files

file filename
8-K - 8-K - LANNETT CO INCa15-20664_18k.htm
EX-99.1 - EX-99.1 - LANNETT CO INCa15-20664_1ex99d1.htm
EX-99.4 - EX-99.4 - LANNETT CO INCa15-20664_1ex99d4.htm
EX-99.2 - EX-99.2 - LANNETT CO INCa15-20664_1ex99d2.htm

Exhibit 99.3

 

Unaudited Pro Forma Combined Financial Statements of Lannett Company, Inc.

 

Lannett Company, Inc. (“Lannett” or “LCI”) expects to complete the acquisition of Kremers Urban Pharmaceuticals Inc. (“KUPI”) for approximately $1.25 billion in aggregate consideration (the “Acquisition”). Lannett anticipates funding the Acquisition with proceeds from the issuance of the $1.16 billion senior secured term loan facility and cash on hand. Lannett obtained commitments for senior secured credit facilities in an aggregate principal amount of up to $1.285 billion comprised of (i) a senior secured term loan facility in an aggregate principal amount of up to $1.16 billion (the “Term Loan Facility”) and (ii) a senior secured revolving credit facility in an aggregate principal amount of up to $125.0 million (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Senior Secured Credit Facility” and, together with the Acquisition, the “Transactions”). Under the terms of the commitment letter relating to the Senior Secured Credit Facility, the Term Loan Facility will be reduced in an amount equal to the proceeds of any debt or equity securities that Lannett issues prior to closing the Acquisition for the purpose of funding the Acquisition.

 

As used herein, the terms “the Company,” “we,” and “our” refer to Lannett Company, Inc., and where applicable, its consolidated subsidiaries. The Company and KUPI have different fiscal year ends. The financial periods presented in this Form 8-K are based on our fiscal periods.  For the purpose of presenting these pro forma financial statements, we used the financial statements for our fiscal year ended June 30, 2015, as filed with the Securities and Exchange Commission (“SEC”) in our most recent Annual Report on Form 10-K. To meet the SEC’s pro forma requirements of combining operating results for KUPI for an annual period that ends within 93 days of the end of our latest annual fiscal period as filed with the SEC, we adjusted KUPI’s historical financial information for the year ended December 31, 2014 to include the interim period ended June 30, 2015 and subtracted the comparable interim period ended June 30, 2014. We combined this KUPI unaudited historical financial information for the twelve months ended June 30, 2015 with our fiscal year ended June 30, 2015 “financial information” to prepare the pro forma financial statements. The Unaudited Pro Forma Combined Balance Sheet as of June 30, 2015 gives effect to the KUPI acquisition as if it had occurred on that date and includes historical data as reported by the separate companies. The Unaudited Pro Forma Combined Statement of Operations for the twelve months ended June 30, 2015 gives effect to the KUPI acquisition as if it had been consummated on July 1, 2014 and includes historical data as reported by the separate companies. The historical financial information has been adjusted to give effect to events that are (i) directly attributable to the acquisition, (ii) factually supportable, and (iii) with respect to the statement of operations, expected to have a continuing impact on the combined results of the companies. The detailed assumptions used to prepare the pro forma financial information are contained in the notes to the Unaudited Pro Forma Combined Financial Statements (“Pro Forma Statements”).

 

The acquisition has been accounted for as a business combination (in accordance with ASC 805 Business Combinations) and, as such, KUPI’s assets acquired and liabilities assumed have been recorded at their respective fair values. The determination of fair value for the identifiable tangible and intangible assets acquired and liabilities assumed requires extensive use of accounting estimates and judgments. Significant estimates and assumptions include, but are not limited to: determining the timing and estimated costs to complete the in-process research and development projects, projecting the likelihood and timing of obtaining regulatory approval, estimating future cash flows and determining the appropriate discount rate. The estimated fair values of the assets acquired and liabilities assumed on the KUPI acquisition date included in the Pro Forma Statements are provisional and subject to change. Any changes to the final fair values could be material.

 

The pro forma adjustments reflecting the consummation of the KUPI acquisition are based upon the acquisition method of accounting in accordance with U.S. generally accepted accounting principles and upon the assumptions set forth in the Notes included in this section. The Pro Forma Statements have been prepared based on available information, using estimates and assumptions that our management believes are reasonable. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Pro Forma Statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions are preliminary and have been made solely for purposes of developing these Pro Forma Statements. The Unaudited Pro Forma Combined Balance Sheet has been adjusted to reflect the allocation of the purchase price to identifiable net assets acquired and of the excess purchase price to goodwill.

 

The Unaudited Pro Forma Combined Statement of Operations does not purport to represent the actual results of operations that would have occurred if the acquisition had taken place on the date specified and are not necessarily indicative of the results of operations that may be achieved in the future. The Unaudited Pro Forma Combined Statement of Operations does not reflect any adjustments for the effect of non-recurring items or operating synergies that we may realize as a result of the acquisition. The Pro Forma Statements include certain reclassifications to conform the historical financial information of KUPI to our presentation (see Note 4 in the accompanying notes).

 

The assumptions used and adjustments made in preparing the Pro Forma Statements are described in the Notes, which should be read in conjunction with the Pro Forma Statements. The Pro Forma Statements and related Notes contained herein should be read in conjunction with the Consolidated Financial Statements and related Notes included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2015.

 

1



 

LANNETT COMPANY, INC.

UNAUDITED PRO FORMA COMBINED BALANCE SHEET

AS OF JUNE 30, 2015

(In thousands)

 

 

 

Lannett Company, Inc.

 

Kremers Urban
Pharmaceuticals Inc.

 

Pro Forma

 

 

 

Lannett Company, Inc.

 

 

 

Historical (1)

 

Reclassified Historical (2)

 

Adjustments (3)

 

 

 

Pro Forma Combined

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

200,340

 

$

1,183

 

$

(114,274

)

(a)

 

$

87,249

 

Investment securities

 

13,467

 

 

 

 

 

13,467

 

Accounts receivable, net

 

91,103

 

199,834

 

 

 

 

290,937

 

Inventories, net

 

46,191

 

61,598

 

26,526

 

(b)

 

134,315

 

Prepaid income taxes

 

 

 

2,370

 

(c)

 

2,370

 

Deferred tax assets

 

16,270

 

38,969

 

(35,073

)

(d)

 

20,166

 

Other current assets

 

3,175

 

1,390

 

 

 

 

4,565

 

Total current assets

 

370,546

 

302,974

 

(120,451

)

 

 

553,069

 

Property, plant, and equipment, net

 

94,556

 

94,113

 

 

 

 

188,669

 

Intangible assets, net

 

29,090

 

5,892

 

618,278

 

(e)

 

653,260

 

Goodwill

 

141

 

177,957

 

107,017

 

(f)

 

285,115

 

Deferred tax assets

 

12,495

 

 

1,095

 

(d)

 

13,590

 

Other assets

 

1,938

 

 

67,295

 

(g)

 

69,233

 

TOTAL ASSETS

 

$

508,766

 

$

580,936

 

$

673,234

 

 

 

$

1,762,936

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

19,195

 

$

16,280

 

$

 

 

 

$

35,475

 

Accrued expenses

 

4,928

 

4,826

 

 

 

 

9,754

 

Accrued payroll and payroll-related expenses

 

10,397

 

10,116

 

4,177

 

(h)

 

24,690

 

Rebates payable

 

7,553

 

8,995

 

 

 

 

16,548

 

Royalties payable

 

 

9,128

 

 

 

 

9,128

 

Income taxes payable

 

1,340

 

 

(1,340

)

(c)

 

 

Current portion of long-term debt

 

135

 

 

11,600

 

(k)

 

11,735

 

Total current liabilities

 

43,548

 

49,345

 

14,437

 

 

 

107,330

 

Long-term debt, less current portion

 

874

 

 

1,148,400

 

(k)

 

1,149,274

 

Acquisition-related contingent consideration

 

 

 

35,000

 

(l)

 

35,000

 

Deferred tax liabilities

 

 

60

 

(60

)

(j)

 

 

Liabilities for uncertain tax positions

 

578

 

34,779

 

(14,404

)

(i)

 

20,953

 

Other long-term liabilities

 

 

1,524

 

510

 

(m)

 

2,034

 

TOTAL LIABILITIES

 

45,000

 

85,708

 

1,183,883

 

 

 

1,314,591

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

37

 

 

 

 

 

37

 

Additional paid-in capital

 

236,178

 

234,668

 

(234,668

)

(n)

 

236,178

 

Retained earnings

 

233,573

 

258,913

 

(274,334

)

(n)

 

218,152

 

Accumulated other comprehensive loss

 

(295

)

1,647

 

(1,647

)

(n)

 

(295

)

Treasury stock

 

(6,080

)

 

 

 

 

(6,080

)

Total Lannett Company, Inc. stockholders’ equity

 

463,413

 

495,228

 

(510,649

)

 

 

447,992

 

Noncontrolling interests

 

353

 

 

 

 

 

353

 

Total stockholders’ equity

 

463,766

 

495,228

 

(510,649

)

 

 

448,345

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

$

508,766

 

$

580,936

 

$

673,234

 

 

 

$

1,762,936

 

 


(1)         Represents audited results for the year ended June 30, 2015 as reported on Form 10-K filed with the SEC on August 27, 2015. Liabilities for uncertain tax positions have been reclassified from Income taxes payable into a separate financial statement line item for purposes of these pro forma financial statements. This reclassification is not significant and does not materially change the historical audited financial statements as reported on our Form 10-K.

(2)         Certain amounts have been reclassified to conform to Lannett’s presentation. Refer to Note 4. Reclassifications below. The accompanying Notes are an integral part of the Unaudited Pro Forma Combined Financial Statements. Kremers Urban Pharmaceuticals Inc. financial data is for the last twelve months ended June 30, 2015.

(3)         See Note 3. Pro Forma Adjustments below.

 

2



 

LANNETT COMPANY, INC.

UNAUDITED PRO FORMA COMBINED STATEMENT OF OPERATIONS

FOR THE TWELVE MONTHS ENDED JUNE 30, 2015

(In thousands)

 

 

 

Lannett Company, Inc.

 

Kremers Urban
Pharmaceuticals Inc.

 

Pro Forma
Adjustments 

 

 

 

Lannett Company, Inc.

 

 

 

Historical (1)

 

Reclassified Historical (2)

 

(3)

 

 

 

Pro Forma Combined

 

Net sales

 

$

406,837

 

$

406,567

 

$

 

 

 

$

813,404

 

Cost of sales

 

100,481

 

238,736

 

30,551

 

(o)

 

369,768

 

Gross profit

 

306,356

 

167,831

 

(30,551

)

 

 

443,636

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

30,342

 

30,292

 

(2,895

)

(p)

 

57,739

 

Selling, general and administrative

 

49,527

 

26,512

 

(8,360

)

(q)

 

67,679

 

Total operating expenses

 

79,869

 

56,804

 

(11,255

)

 

 

125,418

 

Operating income

 

226,487

 

111,027

 

(19,296

)

 

 

318,218

 

Other income (loss):

 

 

 

 

 

 

 

 

 

 

 

Foreign currency loss

 

(21

)

(518

)

 

 

 

(539

)

Gain on sale of assets

 

33

 

50

 

 

 

 

83

 

Gain on investment securities

 

705

 

 

 

 

 

705

 

Interest and dividend income

 

425

 

 

 

 

 

425

 

Interest expense

 

(207

)

 

(67,623

)

(r)

 

(67,830

)

Total other income (loss)

 

935

 

(468

)

(67,623

)

 

 

(67,156

)

Income before income taxes

 

227,422

 

110,559

 

(86,919

)

 

 

251,062

 

Income tax expense

 

77,430

 

25,206

 

(31,352

)

(s)

 

71,284

 

Net income

 

149,992

 

85,353

 

(55,567

)

 

 

179,778

 

Less: Net income attributable to noncontrolling interest

 

73

 

 

 

 

 

73

 

Net income attributable to Lannett Company, Inc.

 

$

149,919

 

$

85,353

 

$

(55,567

)

 

 

$

179,705

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share attributable to Lannett Company, Inc.:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

4.18

 

 

 

 

 

(t)

 

$

5.02

 

Diluted

 

$

4.04

 

 

 

 

 

(t)

 

$

4.84

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

35,827,167

 

 

 

 

 

 

 

35,827,167

 

Diluted

 

37,127,117

 

 

 

 

 

 

 

37,127,117

 

 


(1)         Represents audited results for the year ended June 30, 2015 as reported on Form 10-K filed “with the SEC” on August 27, 2015.

(2)         Certain amounts have been reclassified to conform to Lannett’s presentation. Refer to Note 4. Reclassifications below. The accompanying Notes are an integral part of the Unaudited Pro Forma Combined Financial Statements. Kremers Urban Pharmaceuticals Inc. financial data is for the last twelve months ended June 30, 2015.

(3)         See Note 3. Pro Forma Adjustments below.

 

3



 

LANNETT COMPANY, INC.

NOTES TO UNAUDITED PRO FORMA COMBINED

FINANCIAL STATEMENTS

 

Note 1. Basis of presentation

 

The Unaudited Pro Forma Combined Balance Sheet combines Lannett and KUPI’s historical Consolidated Balance Sheets as of June 30, 2015.

 

The Unaudited Pro Forma Combined Statement of Operations for the twelve months ended June 30, 2015 combines the historical year ended June 30, 2015 results for Lannett and the twelve months ended June 30, 2015 for KUPI to conform to Lannett’s fiscal year end.

 

The Unaudited Pro Forma Combined Statement of Operations does not reflect the non-recurring expenses that we expect to incur in connection with the Acquisition, including fees to financing sources, attorneys, accountants and other professional advisors, the write-off of deferred financing costs, and other transaction-related costs that will not be capitalized. Additionally, the Unaudited Pro Forma Combined Statement of Operations does not reflect the effects of any anticipated cost savings and any related non-recurring costs to achieve those cost savings. The Unaudited Pro Forma Combined Statement of Operations does not purport to represent our actual results of operations that would have occurred if the acquisitions had taken place on the dates specified, nor are they necessarily indicative of the results of operations that may be achieved in the future. The Unaudited Pro Forma Combined Statement of Operations includes certain reclassifications to conform the historical financial information of KUPI to our financial presentation.

 

Note 2. Acquisition of Kremers Urban Pharmaceuticals Inc.

 

Lannett anticipates completing the acquisition of 100% of the outstanding shares of KUPI, upon which KUPI will become a wholly-owned subsidiary of Lannett. KUPI was a privately-held subsidiary of UCB S.A., a specialty generic pharmaceutical company headquartered in Princeton, NJ, focused on difficult-to-formulate products as well as products using different specialized delivery technologies.

 

The following table summarizes the fair value of total consideration transferred to KUPI shareholders assuming an acquisition date of June 30, 2015:

 

(In thousands)

 

 

 

Cash consideration paid to KUPI shareholders (1)

 

$

1,230,000

 

Working capital adjustment (2)

 

(15,340

)

Total cash consideration transferred to KUPI shareholders

 

1,214,660

 

Contingent payment (3)

 

35,000

 

Total consideration transferred to KUPI shareholders

 

$

1,249,660

 

 


(1)  Cash consideration paid to KUPI shareholders will be provided by borrowings under Lannett’s Term Loan Facility and cash on hand.

(2)  Represents the working capital adjustment pursuant to the terms and conditions of the Stock Purchase Agreement dated September 2, 2015.

(3)  Fair value contingent payment of $35 million represents the contingent payment related to the section 338(h)(10) election made pursuant to the Acquisition. Lannett has agreed to a 50/50 split of the additional tax liabilities UCB will incur associated with the section 338(h)(10) election, up to $35 million. We have accounted for this arrangement as contingent consideration and have recorded a liability of $35 million.

 

Assuming an acquisition date of June 30, 2015, the preliminary purchase price of KUPI would have been allocated to the following assets acquired and liabilities assumed:

 

(In thousands)

 

June 30, 2015

 

Accounts receivable, net of revenue-related reserves

 

$

199,834

 

Inventories

 

88,124

 

Deferred tax assets

 

3,896

 

Other current assets

 

1,390

 

Property, plant and equipment

 

94,113

 

Other intangible assets

 

21,170

 

KUPI product rights

 

453,000

 

In-process research and development

 

150,000

 

Goodwill

 

284,974

 

Deferred tax assets

 

1,095

 

Other assets

 

27,995

 

Total assets acquired

 

1,325,591

 

Accounts payable

 

(16,280

)

Accrued expenses

 

(4,826

)

Accrued payroll and payroll-related expenses

 

(14,293

)

Rebates payable

 

(8,995

)

Royalties payable

 

(9,128

)

Liabilities for uncertain tax positions

 

(20,375

)

Other noncurrent liabilities

 

(2,034

)

Total net assets acquired

 

$

1,249,660

 

 

4



 

Note 3.         Pro forma adjustments

 

(a)         The pro forma adjustment to the Cash and cash equivalents balance represents the effects of the following transactions:

 

(In thousands)

 

 

 

Total estimated cash purchase price

 

$

(1,230,000

)

Working capital adjustment (1)

 

15,340

 

Debt proceeds (2)

 

1,120,700

 

Estimated direct transaction costs incurred by LCI in connection with the Acquisition

 

(19,131

)

Elimination of KUPI’s cash (3)

 

(1,183

)

Net pro forma adjustment

 

$

(114,274

)

 


(1) Represents the working capital adjustment pursuant to the terms and conditions of the Stock Purchase Agreement dated September 2, 2015.

(2) Represents $1.16 billion proceeds (see (k)) received in connection with the issuance of the Term Loan Facility to fund a portion of the Acquisition, net of deferred financing fees of $39.3 million (see (g)).

(3) Represents the elimination of KUPI’s cash balance pursuant to the terms and conditions of the Stock Purchase Agreement dated September 2, 2015.

 

(b)         Adjustment is to record the fair value step up for acquired inventory.  Finished goods and work-in-process inventory have been recorded at estimated selling price less the sum of costs of disposal, a reasonable profit allowance for our selling effort, and estimated costs to complete for work-in-process inventory.  Raw material inventory has been valued at current replacement cost, which approximated KUPI’s carrying value.  As there is no continuing impact of the inventory step-up on the Company’s results, the cost of sales associated with the increased inventory value is not included in the Unaudited Pro Forma Combined Statements of Operations.

 

(c)          Included in the total $19.1 million direct transaction costs (see (a)) associated with acquiring KUPI, $10.3 million are estimated to be tax deductible. The adjustment reflects the tax effect of the tax deductible portion.  A portion of this adjustment is netted against our historical income taxes payable balance totaling $1.34 million.

 

(d)         Represents the net decrease in deferred tax assets consisting of (i) a $39.0 million adjustment to remove KUPI’s historical current deferred tax asset, (ii) a $4.0 million adjustment to record the fair value of our current deferred tax assets, and (iii) a $1.1 million adjustment to record the fair value of our non-current deferred tax assets.

 

(e)          The fair value of the intangible assets acquired and related amortization periods, as well as the reversal of KUPI’s historical intangible assets, are reflected in the following pro forma adjustment:

 

(In thousands)

 

 

 

Amortization
Period
(in years)

 

In-process research and development

 

$

150,000

 

 

KUPI product rights

 

453,000

 

15

 

KUPI tradename

 

2,170

 

2

 

Contract manufacturing

 

19,000

 

15

 

Elimination of KUPI’s historical intangible asset value

 

(5,892

)

 

 

Net pro forma adjustment

 

$

618,278

 

 

 

 

Pro forma adjustments related to amortization of definite-lived intangible assets are reflected on the Unaudited Pro Forma Combined Statement of Operations.  See (o), (p), and (q).

 

5



 

The fair value of the KUPI product rights, in-process research and development and contract manufacturing assets were estimated using a discounted present value income approach. Under this method, an intangible asset’s fair value is equal to the present value of the incremental after-tax cash flows (excess earnings) attributable solely to the intangible asset over its remaining useful life. To calculate fair value, the Company used cash flows discounted at rates considered appropriate given the inherent risks associated with each type of asset. The Company believes that the level and timing of cash flows appropriately reflect market participant assumptions. The fair value of the KUPI tradename was estimated using an income approach, specifically known as the relief from royalty method. The relief from royalty method is based on a hypothetical royalty stream that would be received if the Company were to license the KUPI tradename. Thus, we derived the hypothetical royalty income from the projected revenues of KUPI products, respectively. Cash flows were assumed to extend through the remaining economic useful life of each class of intangible asset. These estimates and assumptions are preliminary and have been made solely for purposes of developing these Pro Forma Statements. Any changes to final estimates or amounts could be significant.

 

(f)           Represents the net adjustment to goodwill consisting of (i) the reversal of KUPI’s historical goodwill totaling $178.0 million and (ii) to record goodwill totaling $285.0 million for the excess of the purchase price over the fair value of the tangible and intangible assets acquired and liabilities assumed.

 

(g)          The adjustment consists of the following components:

 

(In thousands)

 

 

 

Deferred financing fees (1)

 

39,300

 

Indemnification asset related to uncertain tax positions (see (i))

 

20,375

 

Indemnification asset related to change-in-control payments (see (h))

 

7,620

 

Net pro forma adjustment

 

$

67,295

 

 


(1)         The deferred financing fees will be amortized over the life of the Revolving Credit Facility and the Term Loan Facility which mature in 2020 and 2022, respectively. The amortization of deferred financing fees is reflected as a pro forma adjustment to the Unaudited Pro Forma Combined Statement of Operations (see (r)).

 

(h)         Represents the net adjustment for change-in-control payments for certain employees in connection with the Acquisition. Adjustment reflects the elimination of KUPI’s historical $3.4 million liability and the recording of $7.6 million (see (g)) to reflect the fair value of the liability assumed.

 

(i)             The net pro forma adjustment includes (i) the elimination of $34.8 million historical KUPI’s liabilities for uncertain tax positions and (ii) the recording of the fair value of the liability assumed related to uncertain tax positions totaling $20.4 million (see (g)).

 

(j)            Represents the adjustment to eliminate KUPI’s historical deferred tax liabilities.

 

(k)         Represents the issuance of the Term Loan Facility to fund a portion of the Acquisition. The adjustment consists of the following components:

 

(In thousands)

 

 

 

Long-term debt, less current portion

 

$

1,148,400

 

Current portion of long-term debt

 

11,600

 

Total Term Loan Facility

 

$

1,160,000

 

 

(l)             Represents the contingent payment related to the section 338(h)(10) election made pursuant to the Acquisition. Lannett has agreed to a 50/50 split of the additional tax liabilities UCB will incur associated with the section 338(h)(10) election, up to $35 million.

 

(m)     Represents the recording of the estimated fair value for the KUPI environmental liability assumed.

 

(n)         Represents the following adjustments to equity:

 

(In thousands)

 

 

 

Elimination of KUPI’s historical additional paid-in capital

 

$

(234,668

)

Elimination of KUPI’s historical retained earnings

 

(258,913

)

Record estimated transaction costs incurred by LCI in connection with the Acquisition, net of $3.7 million tax effect (see (a) and (c))

 

(15,421

)

Elimination of KUPI’s historical accumulated other comprehensive income

 

(1,647

)

Net pro forma adjustment

 

$

(510,649

)

 

6



 

(o)         Adjustment represents the net increase to cost of sales which consists of the following:

 

(In thousands)

 

 

 

Elimination of KUPI’s historical amortization expense

 

$

(916

)

Record amortization expense for acquired definite-lived intangible assets (1)

 

31,467

 

Net pro forma adjustment

 

$

30,551

 

 


(1)         Amortization expense relates to the value of definite-lived intangible assets, recorded over the estimated useful lives of 15 years for currently marketed products and contract manufacturing (see (e)).

 

(p)         Adjustment represents the elimination of KUPI’s historical amortization expense classified as Research and development expense.

 

(q)         Adjustment to Selling, general and administrative expense consists of the following:

 

(In thousands)

 

 

 

Elimination of KUPI’s historical amortization expense

 

$

(467

)

Record amortization expense for the acquired KUPI tradename (1)

 

1,085

 

Elimination of KUPI’s transaction costs (2)

 

(5,732

)

Elimination of KUPI’s change-in-control payments (3)

 

(3,246

)

Net pro forma adjustment

 

$

(8,360

)

 


(1)         Amortization expense relates to the value of the KUPI tradename and is recorded over the estimated useful life of 2 years (see (e)).

(2)         Represents the transaction costs associated with the Acquisition recorded by KUPI for the twelve months ended June 30, 2015. The costs are non-recurring in nature and therefore eliminated for purposes of preparing the Unaudited Pro Forma Combined Statement of Operations.

(3)         Represents the change-in-control payments recorded by KUPI for the twelve months ended June 30, 2015. The payments are non-recurring in nature and therefore eliminated for purposes of preparing the Unaudited Pro Forma Combined Statement of Operations.

 

(r)            Adjustment represents the increase in interest expense, including amortization of deferred financing fees totaling $6.0 million, related to the issuance of the Senior Secured Credit Facility entered into in connection with the Acquisition.  The variable interest rate on the Term Loan Facility was assumed based on the terms of commitment to provide the Senior Secured Credit Facility.  If the Term Loan Facility was outstanding at June 30, 2015, each 1/8% increase in interest rates would yield $1.5 million of incremental annual interest expense.

 

(s)           For purposes of this Unaudited Pro Forma Combined Statement of Operations, an estimated income tax rate of approximately 36% has been used for the pro forma adjustments for the twelve months ended June 30, 2015. The estimated income tax rate is based on the applicable enacted statutory tax rates for the period. These rates are estimates and do not take into account future income tax strategies that may be applied to the combined entity.

 

(t)            The unaudited pro forma combined basic and diluted earnings per share for the period presented are based on the basic and diluted weighted-average number of common shares outstanding. The pro forma combined shares outstanding for the twelve months ended June 30, 2015 are not impacted by the Transactions, and are therefore consistent with Lannett’s basic and diluted shares outstanding for the year ended June 30, 2015.

 

Note 4.         Reclassifications

 

During the preparation of the Pro Forma Statements, we performed a review of KUPI’s accounting policies in an effort to determine if differences in accounting policies require adjustment or reclassification of KUPI’s results of operations or reclassification of assets or liabilities to conform to our accounting policies and classifications.  We were not aware of any material differences between accounting policies of the two companies, except for certain reclassifications necessary to conform to our financial presentation, and accordingly, the Pro Forma Statements do not assume any material differences in accounting policies between the two companies. 

 

7



 

The following identifies the reclassifications made to KUPI’s historical financial statements in order to conform to our financial statement presentation:

 

 

 

KUPI 6/30/15

 

KUPI 6/30/15

 

KUPI 6/30/15

 

(In thousands)

 

Historical

 

Reclassifications

 

Reclassified

 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

1,183

 

$

 

$

1,183

 

Accounts receivable, net

 

188,954

 

10,880

 

199,834

 

Due from affiliates

 

10,880

 

(10,880

)

 

Inventories, net

 

61,598

 

 

61,598

 

Deferred income taxes

 

38,969

 

 

38,969

 

Other current assets

 

1,390

 

 

1,390

 

Total current assets

 

302,974

 

 

302,974

 

Property and equipment, net

 

94,113

 

 

94,113

 

Intangible assets, net

 

5,892

 

 

5,892

 

Goodwill

 

177,957

 

 

177,957

 

Total assets

 

$

580,936

 

$

 

$

580,936

 

 

 

 

 

 

 

 

 

Liabilities and Stockholder’s Equity

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

49,345

 

$

(33,065

)

$

16,280

 

Accrued expenses

 

 

4,826

 

4,826

 

Accrued payroll and payroll-related expenses

 

 

10,116

 

10,116

 

Rebates payable

 

 

8,995

 

8,995

 

Royalties payable

 

 

9,128

 

9,128

 

Total current liabilities

 

49,345

 

 

49,345

 

Deferred income taxes

 

60

 

 

60

 

Liabilities for unrecognized tax benefits

 

34,779

 

 

34,779

 

Other long-term liabilities

 

1,524

 

 

1,524

 

Total liabilities

 

85,708

 

 

85,708

 

 

 

 

 

 

 

 

 

Stockholder’s equity:

 

 

 

 

 

 

 

Additional paid-in capital

 

403,490

 

(168,822

)

234,668

 

Retained earnings

 

258,913

 

 

258,913

 

Receivable from parent

 

(168,822

)

168,822

 

 

Accumulated other comprehensive income

 

1,647

 

 

1,647

 

Total stockholders’ equity

 

495,228

 

 

495,228

 

Total liabilities and stockholder’s equity

 

$

580,936

 

$

 

$

580,936

 

 

 

 

LTM (1)

 

 

 

 

 

(In thousands)

 

KUPI
6/30/15
Historical

 

LTM (1)
KUPI 6/30/15
Reclassifications

 

LTM (1)
KUPI 6/30/15
Reclassified

 

Net sales

 

$

360,165

 

$

46,402

 

$

   406,567

 

Net sales to related party

 

20,174

 

(20,174

)

 

Contract manufacturing revenue

 

32,342

 

(32,342

)

 

Total net revenues

 

412,681

 

(6,114

)

406,567

 

Cost of goods sold

 

207,589

 

31,147

 

238,736

 

Cost of goods sold to related party

 

7,788

 

(7,788

)

 

Contract manufacturing costs

 

18,633

 

(18,633

)

 

Total cost of goods sold

 

234,010

 

4,726

 

238,736

 

Gross profit

 

178,671

 

(10,840

)

167,831

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

29,720

 

572

 

30,292

 

Selling, general and administrative expenses

 

25,910

 

602

 

26,512

 

Selling, general and administrative expenses to related party

 

5,101

 

(5,101

)

 

Other expense, net

 

6,809

 

(6,809

)

 

Total operating expenses

 

67,540

 

(10,736

)

56,804

 

Operating income

 

111,131

 

(104

)

111,027

 

Other income (loss):

 

 

 

 

 

 

 

Foreign currency loss

 

 

(518

)

(518

)

Gain on sale of assets

 

 

50

 

50

 

Total other income (loss)

 

 

(468

)

(468

)

Income before provision for income taxes

 

111,131

 

(572

)

110,559

 

Provision for income taxes

 

25,778

 

(572

)

25,206

 

Net income

 

$

85,353

 

$

 

$

85,353

 

 


(1)         LTM represents the last twelve months ended June 30, 2015 to conform to the Lannett fiscal year end.

 

8